Erasca (ERAS) had the highest return between January 7, 2026 and January 14, 2026 by a mid-cap US stock, returning 122.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Erasca (ERAS) | 1/7/2026 - 1/14/2026 | 122.79% |
Enliven Therapeutics (ELVN) | 1/7/2026 - 1/14/2026 | 72.06% |
MBX Biosciences, Inc Common Stock (MBX) | 1/7/2026 - 1/14/2026 | 43.06% |
Immunitybio (IBRX) | 1/7/2026 - 1/14/2026 | 39.81% |
CG Oncology, Inc Common stock (CGON) | 1/7/2026 - 1/14/2026 | 37.27% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 1/7/2026 - 1/14/2026 | 32.45% |
Kratos Defense & Security Solutions (KTOS) | 1/7/2026 - 1/14/2026 | 31.17% |
Ultra Clean (UCTT) | 1/7/2026 - 1/14/2026 | 30.39% |
Liquidia Technologies (LQDA) | 1/7/2026 - 1/14/2026 | 28.21% |
Neogen (NEOG) | 1/7/2026 - 1/14/2026 | 26.72% |
Dianthus Therapeutics (DNTH) | 1/7/2026 - 1/14/2026 | 26.61% |
Tango Therapeutics (TNGX) | 1/7/2026 - 1/14/2026 | 26.56% |
Ichor (ICHR) | 1/7/2026 - 1/14/2026 | 24.53% |
Beam Therapeutics (BEAM) | 1/7/2026 - 1/14/2026 | 24.16% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 1/7/2026 - 1/14/2026 | 24.03% |
Bilibili (BILI) | 1/7/2026 - 1/14/2026 | 23.34% |
Planet Labs PBC (PL) | 1/7/2026 - 1/14/2026 | 23.07% |
Amylyx Pharmaceuticals (AMLX) | 1/7/2026 - 1/14/2026 | 22.88% |
LandBridge Company LLC (LB) | 1/7/2026 - 1/14/2026 | 22.8% |
Butterfly Network (BFLY) | 1/7/2026 - 1/14/2026 | 22.52% |
Edgewise Therapeutics (EWTX) | 1/7/2026 - 1/14/2026 | 20.95% |
Biohaven (BHVN) | 1/7/2026 - 1/14/2026 | 20.87% |
Astronics (ATRO) | 1/7/2026 - 1/14/2026 | 20.69% |
Uranium Energy (UEC) | 1/7/2026 - 1/14/2026 | 20.55% |
Taseko Mines (TGB) | 1/7/2026 - 1/14/2026 | 20.1% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.